Association between the N-acetylation genetic polymorphism and bronchial asthma

British Journal of Clinical Pharmacology

Volumn 54, Issue 6, 2002, Pages 671-674

  Nacak, Muradiye ^a   Aynacioglu, A Sükrü ^a,b,e   Filiz, Ayten ^a   Cascorbi, Ingolf ^c   Erdal, M Emin ^d   Yilmaz, Necat ^a   Ekinci, Erhan ^a   Roots, Ivar ^e  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b Epidauros Biotechnologie AG   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d MERSIN UNIVERSITY   (Turkey)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Asthma; Molecular genetics; NAT2

Indexed keywords

ACYLTRANSFERASE;

ACETYLATION; ADULT; ALLELE; ALLERGIC ASTHMA; ARTICLE; ASTHMA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; EXTRINSIC ASTHMA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; INTRINSIC ASTHMA; MAJOR CLINICAL STUDY; MALE; MUTANT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE;

EID: 0036904085     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2002.01670.x     Document Type: Article

References (21)

1. Weber WW, Hein DW. N-Acetylation pharmacogenetics. Pharmacol Rev 1985; 37: 25-79.
2. Evans DAP. N-acetyltransferase. In Pharmacogenetics of Drug Metabolism, ed. Kalow, W. New York: Pergamon Press. 1992; 95-178.
3. Hein DW, Ferguson RJ, Doll MA, Rustan TD, Gray K. Molecular genetics of human polymorphic N-acetyltransferase. Enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes. Hum Mol Genet 1994; 3: 729-734.
4. Johns LE, Houlston RS. N-acetyl transferase-2 and bladder cancer risk: A meta-analysis. Environ Mol Mutagen 2000; 36: 221-227.
5. Cascorbi I, Brockmöller J, Mrozikiewicz PM, Bauer S, Loddenkemper R, Roots I. Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as susceptibility for lung cancer. Cancer Res 1996; 56: 3961-3966.
6. Bodansky HJ, Drury PL, Cudworth AG, Evans DAP. Acetylator phenotypes and type I (insulin-dependent) diabetics with microvascular disease. Diabetes 1981; 30: 907-910.
7. Zielinska E, Niewirowski W, Bodalski J, Stanczyk A, Bolanowski W, Rebowski G. Arylamine N-acetyltransferase (NAT2) gene mutations in children with allergic diseases. Clin Pharmacol Ther 1997; 62: 635-642.
8. Gawronska-Szklarz B, Luszawska-Kurtzeba T, Czaja-Bulsa G, Kurtzawski G. Relationship between acetylation polymorphism and risk of atopic diseases. Clin Pharmacol Ther 1999; 65: 562-569.
9. Eden E, Mitchell D, Mehlman B, et al. Atopy, asthma, and emphysema in patients with severe α-1-antitrypysin deficiency. Am J Respir Crit Care Med 1997; 156: 68-74.
10. Walker C. The immunology of extrinsic and intrinsic asthma. Agents Actions Suppl 1993; 3: 97-106.
11. Cascorbi I, Drakoulis N, Brockmöller J, Maurer A, Sperling K, Roots I. Arylamine N-acetyltransferase mutations and their allelic linkage in unrelated Caucasion individuals: Correlation with phenotypic activity. Am J Hum Genet 1995; 57: 581-592.
12. Vatsis KP, Weber WW, Bell DA, et al. Nomenclature for N-acetyltransferases. Pharmacogenetics 1995; 5: 1-17.
13. Griem P, Wulferink M, Sachs B, Gonzalez JB, Gleichmann E. Allergic and autoimmune reactions to xenobiotics: How do they arise? Immunol Today 1998; 19: 133-141.
14. Orzechowska-Juzwenko OK, Milejski P, Patkowski J, Nittner-Marszaeska M, Malolepszy J. Acetylator phenotype in patients with allergic diseases and its clinical significance. Int Clin Pharm Ther Toxicol 1990; 28: 420-425.
15. Schnuch A, Westphal GA, Muller MM, et al. Genotype and phenotype of N-acetyltransferase 2 (NAT2) polymorphisim in patients with contact allergy. Contact Dermatitis 1998; 38: 209-211.
16. Aynacioglu AS, Sachse C, Bozkurt A, et al. Low freqency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population. Clin Pharmacol Ther 1999; 66: 185-192.
17. Aynacioglu AS, Cascorbi I, Mrozikiewicz PM, Roots I. Arylamine N-acetyltransferase (NAT2) genotypes in a Turkish population. Pharmacogenetics 1997; 7: 327-331.
18. Mrozikiewicz PM, Cascorbi I, Brockmöller J, Roots I. Determination and allelic allocation of seven nucleotide transitions within the arylamine N-acetytransferase gene in the Polish population. Clin Pharmacol Ther 1996; 59: 376-382.
19. Sears MR, Burrows B, Flannery EM, Herbison GP, Hewitt CJ, Holdaway MD. Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N Engl J Med 1991; 325: 1067-1071.
20. Wikman H, Piirila P, Rosenberg C, et al. N-Acetyltransferase genotypes as modifiers of diisocyanate exposure-associated asthma risk. Pharmacogenetics 2002; 12: 227-33.
21. Yilmaz N, Bayraktaroglu Z, Ozaslan J. Efficiency of some in vitro allergy tests for evaluating atopy in children and adults. Clin Chem Lab Med 1999; 37: 981-985.